0 items USD 0.00Search
Your search for "Industry SWOT Analysis" gave back 24 results.
Pharmaceutical excipients are inactive substances in the drug which helps in modulating solubility, bioavailability, and stability of active...
IQ4I
July 2019
Price: USD 4,950.00
This report provides you with a landscape description and analysis of degrader-antibody conjugate (DAC) stakeholders, platform technologies,...
颁补迟补濒辞驳:听
La Merie Publishing
September 2024
Price: USD 2,300.00
Artificial Intelligence For Drug Discovery, Biomarker Development and Advanced R&D Landscape Overview Q2/2018 offers comprehensive coverage of...
颁补迟补濒辞驳:听
DKA
August 2018
Price: USD 4,000.00
RNA-Targeted Novel Drug Modalities Based on RNA Editing, Epitranscriptomics, Direct RNA Targeting, Splicing Modulation, Translation Regulation,...
颁补迟补濒辞驳:听
La Merie Publishing
November 2022
Price: USD 2,500.00
鈥淟utetium-177 Global 麻豆原创 Analysis鈥� gives comprehensive insights on the various Lu-177 based drugs being developed for the treatment of GEP-NET,...
IQ4I
February 2020
Price: USD 3,600.00
鈥淣on-alcoholic steatohepataitis (NASH) Pipeline Analysis鈥� gives comprehensive insights on the various drugs being developed for the treatment of NASH...
IQ4I
October 2019
Price: USD 3,600.00
The Competitive Intelligence Report Inhibitors of the bromodomain and extra-terminal domain (BET) family as of January 201 provides a competitor...
颁补迟补濒辞驳:听
La Merie Publishing
January 2016
Price: USD 225.00
Retinoic acid-related orphan nuclear receptor gamma (RORgamma) is a hot, but 鈥瀌ifficult-to-drug鈥� target. More than 30 companies are active in drug...
颁补迟补濒辞驳:听
La Merie Publishing
February 2016
Price: USD 1,050.00
鈥淣onalcoholic steatohepatitis (NASH) Pipeline Analysis鈥� gives comprehensive insight on the various drugs being developed for the treatment of NASH...
颁补迟补濒辞驳:听
IQ4I
July 2015
Price: USD 3,600.00
The Competitive Intelligence report about Alpha Synuclein and LRRK2 Inhibitors - Novel Drug Candidates for Parkinson鈥檚 Disease provides a competitor...
颁补迟补濒辞驳:听
La Merie Publishing
January 2015
Price: USD 249.00
The Competitive Intelligence report about Nonalcoholic Steatohepatitis (NASH) - Novel Drug Candidates provides a competitor analysis in the...
颁补迟补濒辞驳:听
La Merie Publishing
January 2015
Price: USD 249.00
The present Competitive Intelligence report about Cancer Vaccines provides a competitor evaluation in the field of novel prophylactic and therapeutic...
颁补迟补濒辞驳:听
La Merie Publishing
March 2014
Price: USD 1,112.00
Parathyroid hormone/parathyroid hormone-related peptide receptor also known as parathyroid hormone 1 receptor (PTH1R) functions as a receptor for...
颁补迟补濒辞驳:听
La Merie Publishing
October 2013
Price: USD 265.00
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Nicotinamide Riboside (NR) was estimated at US$ 21.46 million in...
颁补迟补濒辞驳:听
MRRPB5
October 2023
Price: USD 4,900.00
Europe drug discovery market was valued at $14.8 billion in 2020 and will grow by 8.3% annually over 2020-2030 owing the rising demand for specialty...
颁补迟补濒辞驳:听
Grace 麻豆原创 Data
November 2021
Price: USD 2,700.00
听
